Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avalo Therapeutics (AVTX) Amortization - Intangibles (2017 - 2022)

Avalo Therapeutics (AVTX) has disclosed Amortization - Intangibles for 6 consecutive years, with $38000.0 as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Amortization - Intangibles fell 91.04% year-over-year to $38000.0, compared with a TTM value of $38000.0 through Dec 2022, down 97.54%, and an annual FY2022 reading of $38000.0, down 97.55% over the prior year.
  • Amortization - Intangibles was $38000.0 for Q1 2022 at Avalo Therapeutics, down from $267000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $1.2 million in Q2 2018 and bottomed at -$1.5 million in Q4 2018.
  • Average Amortization - Intangibles over 5 years is $423331.1, with a median of $424000.0 recorded in 2021.
  • The sharpest move saw Amortization - Intangibles crashed 468.58% in 2018, then skyrocketed 122.51% in 2019.
  • Year by year, Amortization - Intangibles stood at -$1.5 million in 2018, then surged by 122.51% to $334753.0 in 2019, then skyrocketed by 50.38% to $503417.0 in 2020, then crashed by 46.96% to $267000.0 in 2021, then plummeted by 85.77% to $38000.0 in 2022.
  • Business Quant data shows Amortization - Intangibles for AVTX at $38000.0 in Q1 2022, $267000.0 in Q4 2021, and $428000.0 in Q3 2021.